Universitätsklinikum Essen

Characteristics and quality of life of nine-year survivors with metastatic melanoma treated with pembrolizumab beyond second-line therapy (2026) Dugas-Breit S, Forschner A, Erdmann M, Gutzmer R, Kähler KC, Holst I, Brekner A, et al. Journal article Randomized phase 3 trial of Ropeginterferon alfa-2b versus surveillance after tyrosine kinase inhibitor discontinuation in chronic myeloid leukemia (ENDURE/CML-IX). (2026) Burchert A, Nicolini FE, le Coutre P, Saussele S, Hochhaus A, Tuere E, Metzelder SK, et al. Journal article Understanding and leveraging placebo and nocebo effects in perioperative care: a cross-sectional survey of German-speaking anesthesiologists (2026) Wessels J, Pawlik RJ, Foerster C, Erlenwein J, Benson S, Sondermann W, Elsenbruch S, Aulenkamp J Journal article Follow-Up Care after Adult Lung Transplantation: Summary of an Evidence-Based Clinical Practice Guideline for German-Speaking Countries (2026) Gottlieb J, Wald A, Bucher B, Tapp B, Hirsch C, Schneider C, Winter H, et al. Journal article Geriatric medicine shapes the Future: Recommendations for modern Geriatric Medicine that places older people and their needs at the centre Geriatrie gestaltet Zukunft: Forderungen für eine moderne Altersmedizin, die ältere Menschen und deren Bedürfnisse ins Zentrum stellt (2026) Gosch M, Bauer J, Bollheimer C, Dodel R, Gollasch M, Heppner HJ, Hofbauer L, et al. Journal article Fumarate hydratase-deficient renal cell carcinoma – results of the exploratory analysis in the SUNNIFORECAST trial comparing Ipilimumab plus Nivolumab vs standard of care as first line treatment (2026) Ahrens M, Haanen J, Albiges L, Goupil MG, Boleti E, Gravis G, Fléchon A, et al. Journal article IDH1-mutant vaccine in newly diagnosed astrocytoma: final analysis of the multicenter, single-arm, open-label, first-in-human phase 1 NOA16 trial (2026) Bunse L, Lindner K, Wick A, Freitag A, Lanz LM, Edelmann D, Suwala A, et al. Journal article IDH2 clonal hematopoiesis and IKAROS loss cooperate in a B-ALL subtype after lenalidomide therapy for multiple myeloma (2026) Horns JM, Beder T, Künstner A, Barz MJ, Bendig S, Bozzetti C, Chitadze G, et al. Journal article Risk-adapted HLA delisting and imlifidase-enabled deceased-donor kidney transplantation in highly sensitized kidney transplant candidates: a German expert consensus report (2026) Reuter S, Benning L, Dick A, Dilz LM, Einecke G, Emmerich F, Grahammer F, et al. Journal article Phenotypic intrafamilial variability of 5q-associated spinal muscular atrophy: A systematic multicentre sibling study. (2026) Becker B, Cordts I, Becker J, Günther R, Baumann M, Bernert G, Eisenkölbl A, et al. Journal article